SHIFT AI Newsroom · GLOBAL

Semaglutide's Potential in Restoring Ovulation for Polycystic Ovary Syndrome

A clinical trial is investigating the role of Semaglutide in restoring ovulation in youth and adults with Polycystic Ovary Syndrome.

Published 2026-09-10 · Evidence level 2

A clinical trial has been registered to investigate the role of Semaglutide in restoring ovulation in youth and adults with Polycystic Ovary Syndrome. The trial aims to provide insight into a potential new treatment option for this common endocrine disorder.

What this means in the UK

This trial may provide insight into a potential new treatment option for individuals in the UK with Polycystic Ovary Syndrome, a common endocrine disorder affecting women of reproductive age.

Known facts

  • A clinical trial is investigating the use of Semaglutide to restore ovulation in individuals with Polycystic Ovary Syndrome.

Sources and evidence

← Back to SHIFT AI Newsroom